Evidence mapPaperPMID 39589556Full record

ArticleCell biology and toxicology2024

Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.

Yetong Feng, Mengjiao Shi, Yi Zhang, Xinyan Li, Liangwen Yan, Jiayi Xu, Chenyue Liu, Miaomiao Li, Fengyun Bai, Fenyue Yuan and 9 more

Abstract read
In one paragraph

Article in Cell biology and toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yetong Feng *Department of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Mengjiao Shi *Department of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yi Zhang *International Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xinyan LiInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Liangwen YanInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jiayi XuInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Chenyue LiuDepartment of Medical Image, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Miaomiao LiInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Fengyun BaiShaanxi Dongtai Pharmaceutical Co., LTD, Xianyang, China.
Fenyue YuanShaanxi Dongtai Pharmaceutical Co., LTD, Xianyang, China.
Ying SunShaanxi Dongtai Pharmaceutical Co., LTD, Xianyang, China.
Rongrong LiuInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yaping ZhaoInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Lan YangDepartment of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Yinggang ZhangInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Ying GuoInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jian ZhangDepartment of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. zhangjian_xjtu@126.com.
Rui ZhouDepartment of General Surgery, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. zhourui0317@163.com.
Pengfei LiuInternational Joint Research Center On Cell Stress and Disease Diagnosis and Therapy, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. liupengfei@xjtu.edu.cn.

Funding

Innovation Capability Support Program of Shaanxi Province 2023KJXX-033Key Research and Development Program of Shaanxi Province 2022-LL-JB-30Medical "Base-Clinic" Integrated Innovation Project of Xi'an Jiaotong University YXJLRH2022058National Natural Science Foundation of China 82370583Natural Science Basic Research Program of Shaanxi Province 2024JC-YBQN-0091Natural Science Foundation of Shaanxi Province 2020JQ-541Research Foundation of the Second Affiliated Hospital of Xi'an Jiaotong University YJ(QN)202301Science and Technology Program of Xi'an City 23YXYJ0125Shaanxi Fundamental Science Research Project for Chemistry and Biology 23JHQ036the Fundamental Research Funds for the Central Universities xzy012023120 and xzd012024061"The Young Talent Support Plan" of Xi'an Jiaotong University RCYJ0013
6 · The paper itself

Abstract

Ferroptosis represents a newly programmed cell death, and the process is usually accompanied with iron-dependent lipid peroxidation. Importantly, ferroptosis is implicated in a myriad of diseases. Recent literature suggests a potential position of ferroptosis in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD), the most widespread liver ailment worldwide. Intriguingly, several functional genes and metabolic pathways central to ferroptosis are regulated by nuclear factor erythroid-derived 2-like 2 (NRF2). In current work, we aim to identify protocatechuic acid (PCA), a primary metabolite of antioxidant polyphenols, as a potent NRF2 activator and ferroptosis inhibitor in the hepatic lipotoxicity and steatosis models. Herein, both NRF2

Indexed as

Fatty LiverFerroptosisHydroxybenzoatesLiverNF-E2-Related Factor 2Signal TransductionAnimalsDiet, High-FatHumansMaleMiceMice, Inbred C57BLPalmitic AcidHydroxybenzoatesNfe2l2 protein, mouseNF-E2-Related Factor 2Palmitic Acidprotocatechuic acidFerroptosisLipotoxicityNonalcoholic fatty liver diseaseNRF2Protocatechuic acid

Identifiers

PMID39589556
PMCPMC11599353

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.